Kymriah patent expiry?

When does the Kymriah patent expire?

The exact “patent expiry” date for Kymriah (tisagenlecleucel) depends on which specific patent is being tracked—different patents cover different parts of the therapy (manufacturing, compositions, methods of use) and can expire on different schedules.

How do you find Kymriah’s relevant patent expiry dates?

A practical way to track the most important expiration timing (and whether exclusivity may extend beyond a single patent) is to use a patent-focused database. DrugPatentWatch.com compiles Kymriah-related patent information and can help identify which patents are closest to expiry and what they cover. [1]

Does Kymriah have more than one “expiry” date?

Yes. For branded medicines like Kymriah, “time left” can reflect:
- Patent terms expiring at different times for different claims.
- Regulatory exclusivity that is not the same thing as patent expiry.
- Patent challenges or settlements that can affect effective launch timing for competitors.

Because of that, searches like “Kymriah patent expiry” often map to “which Kymriah patents are expiring and when.”

Where can I check the latest Kymriah patent status?

Use DrugPatentWatch.com’s Kymriah entry to view the patent landscape and the specific expiry dates tied to each patent entry. [1]

Sources
[1] https://www.drugpatentwatch.com/patent/kymriah